"It is very important to us to provide our patients and caregivers with the most meaningful information with regards to patient health," said Terry Duesterhoeft, vice president of Marketing & Sales, Honeywell. "As we developed the Genesis DM, we closely evaluated the entire patient environment and discovered that the integration of all data (both objective and subjective) truly differentiated this product in the overall telehealth ecosystem."
The Medical Design Excellence Awards, now in its eleventh year, recognizes companies and individuals worldwide involved in the design, engineering, manufacture or distribution of finished medical devices or medical packaging. Entries are evaluated by a multidisciplinary panel of jurors with expertise in engineering, medicine, industrial design, manufacturing and other design -- and healthcare-related fields.
For more information about Honeywell HomMed's telehealth solutions, visit http://www.hommed.com.
Honeywell International is a $36 billion diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; automotive products; turbochargers; and specialty materials. Based in Morris Township, N.J., Honeywell's shares are traded on the New York, London and Chicago Stock Exchanges. For additional information, please visit http://www.honeywell.com.
Forward Looking Statement
This release contains "forward-looking statements" within the meaning
of Section 21E of the Securities Exchange Act of 1934. All statements,
other than statements of fact, that address activities, events or
developments that we or our management intend, expect, project, believe or
Copyright©2008 PR Newswire.
All rights reserved